BIOFIRE DEFENSE LLC climbed the most in the contractor rankings
#13→#3Up 10 places
The contractor accounts for 5.3% of positive obligations across 12 reported actions.
Federal Capture Intelligence
In-Vitro Diagnostic Substance Manufacturing contractors at the Department of Defense
Contract actions: October 1, 2021 – July 27, 2026
Updated July 28, 2026 Department of Defense agency guide
NAICS 325413 · In-Vitro Diagnostic Substance Manufacturing
- Latest 12 months
- $52.7M
- Net obligations · Up $7.6M vs. $45.2M preceding
- Prime contractors
- 105
- With positive obligations in the latest 12 months
Market snapshot for In-Vitro Diagnostic Substance Manufacturing at the Department of Defense
Federal records show $5.4B in net obligations across 3,519 awards in In-Vitro Diagnostic Substance Manufacturing at the Department of Defense from Oct 1, 2021 through Jul 27, 2026. This market accounts for 0.26% of $2.1T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 16.7% from $45.2M to $52.7M. 21 prime contractors accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Jul 27, 2026; earlier years show complete fiscal-year totals.
FY26 year-to-date: $47.8M versus $43.8M through the same date in FY25 (+9.1%).
Net obligations · complete fiscal yearNet obligations · FY26 YTDContract actions
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $4.8B | 1,660 | Complete |
| FY2023 | $547.3M | 1,330 | Complete |
| FY2024 | $50.3M | 1,253 | Complete |
| FY2025 | $48.8M | 1,323 | Complete |
| FY2026 | $47.8M | 731 | YTD through Jul 27, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $5.4B
- 3,519 awards · 220 prime contractors
- Latest 12-month movement
- +16.7%
- $52.7M vs. $45.2M
- Leading eight prime share
- 50.5%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 0.26% of $2.1T in agency-wide net obligations.
- Set-aside share when reported
- 2.4% of 2,265 awards with reported set-aside status.
- Set-aside reporting
- 55 set aside · 2,210 no set-aside · 1,254 not reported
What changed in the last 12 months?
Jul 28, 2025–Jul 27, 2026, compared with Jul 28, 2024–Jul 27, 2025.
Competitive shifts
HOLOGIC, INC. fell the most in the contractor rankings
#9→#58Down 49 places
The contractor accounts for 0.14% of positive obligations across 7 reported actions.
ROCHE DIAGNOSTICS CORPORATION gained the most market share
11.1%→16.9%+5.8 percentage points
The contractor now ranks #1 by positive obligations, based on 62 reported actions.
ORTHO-CLINICAL DIAGNOSTICS, INC lost the most market share
4.5%→1.0%−3.5 percentage points
The contractor now ranks #25 by positive obligations, based on 18 reported actions.
Buyer demand
Reported obligations through 88TH MDSS SGSL - PA increased
$277K→$4.1M+$3.8M
Latest-period activity spans 31 awards across 6 prime contractors.
Reported obligations through AMC BRAGG - MM decreased
$2.5M→$696K−$1.8M
Latest-period activity spans 2 awards across 2 prime contractors.
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Funding pattern for In-Vitro Diagnostic Substance Manufacturing at the Department of Defense
See how positive obligations were attributed across funding offices in the 12 months ending Jul 27, 2026.
13.4% of positive obligations were attributed to AMC BAMC FSH - MM. That represents $7.1M, up $9.8M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- AMC BAMC FSH - MM13.4% · $7.1M · up $9.8M
- AMC MADIGAN LEWIS - MM9.4% · $5.0M · up $3.4M
- 88TH MDSS SGSL - PA7.8% · $4.1M · up $3.8M
- AMC TRIPLER SHAFTER - MM6.1% · $3.2M · down $804K
- AMC BEAUMONT BLISS - MM4.7% · $2.5M · up $944K
- All other reported offices58.7% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
AMC BAMC FSH - MM
#1New to the positive-obligation rankingLatest 12 months
$7.1M
13.4% of positive obligations
Versus preceding 12 months
+$9.8M
23 active prime contractors · 28 awards
View office comparison and evidence
Reported obligations moved from $2.8M in net deobligations to $7.1M in net obligations. The office’s share of positive obligations moved from 0% to 13.4%, a change of +13.4 percentage points.
The latest period contains 78 actions across 28 awards and 4 newly active prime contractors. The preceding period contained 20 active prime contractors and 29 awards.
Leading award-level changes
- ROCHE DIAGNOSTICS CORPORATION · PIID W81K0025FA207+$1.7M: $0 → $1.7M
- ROCHE DIAGNOSTICS CORPORATION · PIID W81K0021P0269+$1.5M: −$1.5M → $0
Reported funding office
AMC MADIGAN LEWIS - MM
#2Up 7 from #9Latest 12 months
$5.0M
9.4% of positive obligations
Versus preceding 12 months
+$3.4M
16 active prime contractors · 26 awards
View office comparison and evidence
Reported obligations increased 209.7% from $1.6M to $5.0M. The office’s share of positive obligations moved from 3.3% to 9.4%, a change of +6.1 percentage points.
The latest period contains 68 actions across 26 awards and 9 newly active prime contractors. The preceding period contained 10 active prime contractors and 12 awards.
Reported funding office
88TH MDSS SGSL - PA
#3Up 33 from #36Latest 12 months
$4.1M
7.8% of positive obligations
Versus preceding 12 months
+$3.8M
6 active prime contractors · 31 awards
View office comparison and evidence
Reported obligations increased 1391.1% from $277K to $4.1M. The office’s share of positive obligations moved from 0.57% to 7.8%, a change of +7.2 percentage points.
The latest period contains 33 actions across 31 awards and 2 newly active prime contractors. The preceding period contained 4 active prime contractors and 10 awards.
Reported funding office
AMC TRIPLER SHAFTER - MM
#4Down 2 from #2Latest 12 months
$3.2M
6.1% of positive obligations
Versus preceding 12 months
−$804K
14 active prime contractors · 15 awards
View office comparison and evidence
Reported obligations decreased 20.0% from $4.0M to $3.2M. The office’s share of positive obligations moved from 8.3% to 6.1%, a change of −2.2 percentage points.
The latest period contains 45 actions across 15 awards and 2 newly active prime contractors. The preceding period contained 16 active prime contractors and 21 awards.
Reported funding office
AMC BEAUMONT BLISS - MM
#5Up 6 from #11Latest 12 months
$2.5M
4.7% of positive obligations
Versus preceding 12 months
+$944K
7 active prime contractors · 9 awards
View office comparison and evidence
Reported obligations increased 60.9% from $1.6M to $2.5M. The office’s share of positive obligations moved from 3.2% to 4.7%, a change of +1.5 percentage points.
The latest period contains 18 actions across 9 awards and 2 newly active prime contractors. The preceding period contained 8 active prime contractors and 10 awards.
Reported funding office
ACH BENNING - MM
#6Down 1 from #5Latest 12 months
$2.2M
4.1% of positive obligations
Versus preceding 12 months
+$321K
8 active prime contractors · 9 awards
View office comparison and evidence
Reported obligations increased 17.2% from $1.9M to $2.2M. The office’s share of positive obligations moved from 3.9% to 4.1%, a change of +0.3 percentage points.
The latest period contains 21 actions across 9 awards and 2 newly active prime contractors. The preceding period contained 9 active prime contractors and 13 awards.
Reported funding office
DIRECTOR, WRNMMC
#7Down 3 from #4Latest 12 months
$2.1M
3.9% of positive obligations
Versus preceding 12 months
−$348K
5 active prime contractors · 7 awards
View office comparison and evidence
Reported obligations decreased 14.4% from $2.4M to $2.1M. The office’s share of positive obligations moved from 5.0% to 3.9%, a change of −1.1 percentage points.
The latest period contains 9 actions across 7 awards and 2 newly active prime contractors. The preceding period contained 9 active prime contractors and 11 awards.
Reported funding office
LANDSTUHL RMC - MM
#8Down 2 from #6Latest 12 months
$1.9M
3.7% of positive obligations
Versus preceding 12 months
+$275K
6 active prime contractors · 9 awards
View office comparison and evidence
Reported obligations increased 16.4% from $1.7M to $1.9M. The office’s share of positive obligations moved from 3.5% to 3.7%, a change of +0.2 percentage points.
The latest period contains 31 actions across 9 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 9 awards.
Reported funding office
AHC MONCRIEF JACKSON - MM
#9Up 11 from #20Latest 12 months
$1.8M
3.3% of positive obligations
Versus preceding 12 months
+$952K
5 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations increased 116.8% from $815K to $1.8M. The office’s share of positive obligations moved from 1.7% to 3.3%, a change of +1.7 percentage points.
The latest period contains 12 actions across 5 awards. The preceding period contained 5 active prime contractors and 5 awards.
Reported funding office
ACH BRIAN ALLGOOD - PA
#10Rank unchangedLatest 12 months
$1.5M
2.8% of positive obligations
Versus preceding 12 months
−$63K
11 active prime contractors · 15 awards
View office comparison and evidence
Reported obligations decreased 4.1% from $1.6M to $1.5M. The office’s share of positive obligations moved from 3.2% to 2.8%, a change of −0.4 percentage points.
The latest period contains 52 actions across 15 awards and 1 newly active prime contractor. The preceding period contained 14 active prime contractors and 27 awards.
Reported funding office
AMC BRAGG - MM
#20Down 17 from #3Latest 12 months
$696K
1.3% of positive obligations
Versus preceding 12 months
−$1.8M
2 active prime contractors · 2 awards
View office comparison and evidence
Reported obligations decreased 71.9% from $2.5M to $696K. The office’s share of positive obligations moved from 5.1% to 1.3%, a change of −3.8 percentage points.
The latest period contains 6 actions across 2 awards. The preceding period contained 4 active prime contractors and 4 awards.
Reported funding office
W40M MRC0 WEST
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$4.8M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $4.8M to $0. The office’s share of positive obligations moved from 9.9% to 0%, a change of −9.9 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 15 active prime contractors and 16 awards.
Leading award-level changes
- BIOFIRE DIAGNOSTICS LLC · PIID W81K0020P0348−$933K: $933K → $0
- ROCHE DIAGNOSTICS CORPORATION · PIID W81K0023P0198−$841K: $841K → $0
Reported funding office
W2DN BROOKE AMC
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$1.6M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $1.6M to $0. The office’s share of positive obligations moved from 3.4% to 0%, a change of −3.4 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 4 active prime contractors and 5 awards.
Reported funding office
AMC BEAUMONT BLISS - PB
No positive-obligation rankLatest 12 months
−$94K
0% of positive obligations
Versus preceding 12 months
−$1.7M
4 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations moved from $1.6M in net obligations to $94K in net deobligations. The office’s share of positive obligations moved from 3.3% to 0%, a change of −3.3 percentage points.
The latest period contains 5 actions across 5 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 6 awards.
Reported funding office
USNAV HOSPITAL OKINAWA - MM
No positive-obligation rankLatest 12 months
−$118K
0% of positive obligations
Versus preceding 12 months
−$1.2M
10 active prime contractors · 10 awards
View office comparison and evidence
Reported obligations moved from $1.0M in net obligations to $118K in net deobligations. The office’s share of positive obligations moved from 2.2% to 0%, a change of −2.2 percentage points.
The latest period contains 22 actions across 10 awards and 1 newly active prime contractor. The preceding period contained 13 active prime contractors and 15 awards.
How this work is bought
Reported award structure, competition, pricing, work categories, and contracting channels for In-Vitro Diagnostic Substance Manufacturing at the Department of Defense.
During Jul 28, 2025–Jul 27, 2026, this market recorded $55.9M in positive net award obligations across 612 awards. The leading reported procedure, Simplified Acquisition, accounted for 77.0% of that positive-obligation base. Awards with a reported parent IDV accounted for 42.7%.
- Leading award type
- 46.1%
- Purchase Order
- Leading reported procedure
- 77.0%
- Simplified Acquisition
- Reported parent IDV
- 42.7%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 474 of 612 awards reported offers
Buying method changes
Compared with Jul 28, 2024–Jul 27, 2025. Based on 612 current awards and 771 preceding awards with positive net obligations.
- Median positive award obligations
- $23K
- Up from $13K in the preceding period
- Parent-IDV obligation share
- 42.7%
- Up from 30.6% in the preceding period
How to read these changes
Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.
Same-NAICS comparison
Compared with the NAICS 325413 peer median, parent-IDV obligation share is 33.9 percentage points lower, reported full-and-open obligation share is 8.7 percentage points lower, delivery-order obligation share is 18.0 percentage points lower, and median positive award obligations are 48.4% lower.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 42.7% | 76.7% | -33.9 pts |
| Reported full-and-open obligation share | 9.7% | 18.4% | -8.7 pts |
| Delivery-order obligation share | 27.4% | 45.3% | -18.0 pts |
| Median positive award obligations | $23K | $45K | -48.4% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
- Department of Agriculture (USDA)
- Department of Health and Human Services (HHS)
- Department of Veterans Affairs (VA)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Purchase Order(B) | 341 | $25.8M | 46.1% |
| Delivery Order(C) | 147 | $15.3M | 27.4% |
| BPA Call(A) | 102 | $8.6M | 15.4% |
| Definitive Contract(D) | 22 | $6.3M | 11.2% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 138 | $15.0M | 26.8% |
| BPA(E) | 102 | $8.6M | 15.4% |
| FSS(C) | 9 | $327K | 0.58% |
| Not reported | 363 | $32.0M | 57.3% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 240 | $23.6M | 42.2% |
| Multiple Award(M) | 9 | $327K | 0.58% |
| Not reported | 363 | $32.0M | 57.3% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Simplified Acquisition(SP1) | 542 | $43.1M | 77.0% |
| Only One Source(SSS) | 39 | $7.3M | 13.1% |
| Negotiated Proposal/Quote(NP) | 22 | $5.2M | 9.3% |
| Subject To Multiple Award Fair Opportunity(MAFO) | 9 | $327K | 0.58% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Competed Under SAP(F) | 398 | $22.4M | 40.0% |
| Not Competed Under SAP(G) | 144 | $20.7M | 37.0% |
| Not Competed(C) | 39 | $7.3M | 13.1% |
| Full And Open Competition(A) | 30 | $5.4M | 9.7% |
| Full And Open Competition After Exclusion Of Sources(D) | 1 | $117K | 0.21% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source - Other(ONE) | 6 | $203K | 0.36% |
| Fair Opportunity Given(FAIR) | 3 | $124K | 0.22% |
| Not reported | 603 | $55.6M | 99.4% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| SAP Non-Competition (FAR 13)(SP2) | 141 | $18.3M | 32.7% |
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 36 | $7.2M | 12.8% |
| Authorized By Statute (FAR 6.302-5(A)(2)(I))(OTH) | 3 | $2.4M | 4.3% |
| Brand Name Description (FAR 6.302-1(C))(BND) | 3 | $191K | 0.34% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 1 | $73K | 0.13% |
| Not reported | 428 | $27.8M | 49.8% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 612 | $55.9M | 100.0% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| In Vitro Diagnostic Substances, Reagents, Test Kits And Sets(6550) | 502 | $41.3M | 73.8% |
| Medical And Surgical Instruments, Equipment, And Supplies(6515) | 36 | $5.0M | 9.0% |
| Drugs And Biologicals(6505) | 15 | $4.5M | 8.0% |
| Laboratory Equipment And Supplies(6640) | 29 | $2.5M | 4.5% |
| Lease Or Rental Of Equipment- Medical, Dental, And Veterinary Equipment And Supplies(W065) | 2 | $782K | 1.4% |
| Chemical Analysis Instruments(6630) | 3 | $631K | 1.1% |
| Other reported values | 25 | $1.2M | 2.2% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Department of the Army(2100) | 135 | $27.0M | 48.3% |
| Defense Health Agency(97DH) | 159 | $20.1M | 36.0% |
| Department of the Air Force(5700) | 48 | $5.1M | 9.1% |
| Department of the Navy(1700) | 72 | $2.1M | 3.7% |
| Defense Logistics Agency(97AS) | 198 | $1.6M | 2.8% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| W40m Mrc0 West(W81K00) | 78 | $20.4M | 36.5% |
| Defense Health Agency Hcd West(HT9410) | 59 | $10.4M | 18.6% |
| Fa2396 Usaf Afmc Afrl Pzl Afrl Pzle(FA2396) | 31 | $4.1M | 7.4% |
| Defense Health Agency(HT9406) | 21 | $3.6M | 6.4% |
| W40m Mrco Pacific(W81K02) | 24 | $3.0M | 5.3% |
| Defense Health Agency(HT0014) | 12 | $2.4M | 4.4% |
| Other reported values | 387 | $11.9M | 21.3% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| FA239625AB002(9700) | 8 | $2.7M | 4.9% |
| W81K0225DA021(9700) | 1 | $1.9M | 3.5% |
| W81K0025DA002(9700) | 1 | $1.7M | 3.1% |
| W9114F24D0005(9700) | 3 | $1.6M | 2.9% |
| SPE8EQ25D0004(9700) | 10 | $1.3M | 2.4% |
| W81K0023D0005(9700) | 1 | $1.1M | 1.9% |
| N6264523D5013(9700) | 10 | $980K | 1.8% |
| W81K0225DA010(9700) | 1 | $968K | 1.7% |
| Other reported values | 214 | $11.5M | 20.6% |
| Not reported | 363 | $32.0M | 57.3% |
Offers, award size, and timing
- Median reported offers
- 1 median
- 474 reported · 138 not reported
- Positive award obligations
- $23K median
- $2K–$78K middle 50%
- Reported performance period
- 77 days (~3 months) median
- 611 reported · 1 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Jul 27, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Prime contractors for In-Vitro Diagnostic Substance Manufacturing at the Department of Defense
Latest 12-month concentration and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 21 of 105prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 16.9%of positive obligations in the last 12 months
- Leading four prime contractors
- 33.4%of positive obligations in the last 12 months
- Leading eight prime contractors
- 50.5%of positive obligations in the last 12 months
Based on $53.5M in positive obligations during the 12 months ending Jul 27, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Jul 28, 2024–Jul 27, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
15 leading contractors
- #1
Last 12mo obligations
$9.1M
16.9%
Dollar movement
+$4.0M
vs. prior 12 months
Last 12mo awards
29 awards
62 actions
Historical and award details for ROCHE DIAGNOSTICS CORPORATION
- Obligations: prior → latest
- $5.0M → $9.1M
- +79.3%
- Share: prior → latest
- 11.1% → 16.9%
- +5.8 percentage points
- All-period obligations
- $610.9M
- 11.2% of all-period positive obligations · 69 awards
- Recorded activity
- Since Oct 4, 2021
- through Apr 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 25 21 Not reported 4 4 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$3.4M
6.5%
Dollar movement
−$395K
vs. prior 12 months
Last 12mo awards
19 awards
37 actions
Historical and award details for HOLOGIC SALES AND SERVICE, LLC
- Obligations: prior → latest
- $3.8M → $3.4M
- −10.3%
- Share: prior → latest
- 8.5% → 6.5%
- −2.0 percentage points
- All-period obligations
- $14.6M
- 0.27% of all-period positive obligations · 51 awards
- Recorded activity
- Since Oct 6, 2021
- through Apr 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 19 20 Not reported 0 1 Reported small business 1 1 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$2.8M
5.3%
Dollar movement
+$1.8M
vs. prior 12 months
Last 12mo awards
5 awards
12 actions
Historical and award details for BIOFIRE DEFENSE LLC
- Obligations: prior → latest
- $1000K → $2.8M
- +181.3%
- Share: prior → latest
- 2.2% → 5.3%
- +3.1 percentage points
- All-period obligations
- $8.1M
- 0.15% of all-period positive obligations · 21 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 4 5 Not reported 1 0 Reported small business 2 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$2.5M
4.7%
Dollar movement
+$925K
vs. prior 12 months
Last 12mo awards
17 awards
38 actions
Historical and award details for BECKMAN COULTER, INC
- Obligations: prior → latest
- $1.6M → $2.5M
- +57.7%
- Share: prior → latest
- 3.5% → 4.7%
- +1.2 percentage points
- All-period obligations
- $9.7M
- 0.18% of all-period positive obligations · 52 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 17 28 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$2.4M
4.4%
Dollar movement
−$206K
vs. prior 12 months
Last 12mo awards
40 awards
53 actions
Historical and award details for SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Obligations: prior → latest
- $2.6M → $2.4M
- −8.0%
- Share: prior → latest
- 5.7% → 4.4%
- −1.2 percentage points
- All-period obligations
- $609.7M
- 11.2% of all-period positive obligations · 277 awards
- Recorded activity
- Since Oct 4, 2021
- through Apr 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 11 16 Not reported 29 45 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$2.3M
4.3%
Dollar movement
+$1.3M
vs. prior 12 months
Last 12mo awards
13 awards
27 actions
Historical and award details for DIASORIN INC
- Obligations: prior → latest
- $1.0M → $2.3M
- +125.3%
- Share: prior → latest
- 2.3% → 4.3%
- +2.1 percentage points
- All-period obligations
- $5.3M
- 0.10% of all-period positive obligations · 28 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 2, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 11 11 Not reported 2 0 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$2.2M
4.2%
Dollar movement
−$132K
vs. prior 12 months
Last 12mo awards
20 awards
33 actions
Historical and award details for ABBOTT LABORATORIES INC.
- Obligations: prior → latest
- $2.4M → $2.2M
- −5.6%
- Share: prior → latest
- 5.2% → 4.2%
- −1.0 percentage points
- All-period obligations
- $14.3M
- 0.26% of all-period positive obligations · 69 awards
- Recorded activity
- Since Oct 14, 2021
- through Apr 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 20 22 Not reported 0 2 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$2.2M
4.2%
Dollar movement
+$2.2M
vs. prior 12 months
Last 12mo awards
20 awards
39 actions
Historical and award details for QUIDELORTHO SALES COMPANY, LLC
- Obligations: prior → latest
- $0 → $2.2M
- Not comparable
- Share: prior → latest
- 0% → 4.2%
- +4.2 percentage points
- All-period obligations
- $2.2M
- 0.040% of all-period positive obligations · 20 awards
- Recorded activity
- Since Jul 17, 2025
- through Apr 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 13 1 Not reported 7 0 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$1.8M
3.4%
Dollar movement
+$90K
vs. prior 12 months
Last 12mo awards
14 awards
30 actions
Historical and award details for SYSMEX AMERICA, INC
- Obligations: prior → latest
- $1.7M → $1.8M
- +5.2%
- Share: prior → latest
- 3.8% → 3.4%
- −0.4 percentage points
- All-period obligations
- $7.9M
- 0.14% of all-period positive obligations · 26 awards
- Recorded activity
- Since Oct 12, 2021
- through Apr 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 14 16 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$1.7M
3.2%
Dollar movement
+$194K
vs. prior 12 months
Last 12mo awards
6 awards
15 actions
Historical and award details for CEPHEID
- Obligations: prior → latest
- $1.5M → $1.7M
- +12.9%
- Share: prior → latest
- 3.3% → 3.2%
- −0.1 percentage points
- All-period obligations
- $9.5M
- 0.17% of all-period positive obligations · 23 awards
- Recorded activity
- Since Oct 13, 2021
- through Apr 6, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 6 Not reported 3 3 Reported small business 0 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$1.7M
3.1%
Dollar movement
+$1.7M
vs. prior 12 months
Last 12mo awards
2 awards
3 actions
Historical and award details for ABBOTT MOLECULAR INC.
- Obligations: prior → latest
- $0 → $1.7M
- Not comparable
- Share: prior → latest
- 0% → 3.1%
- +3.1 percentage points
- All-period obligations
- $1.8M
- 0.030% of all-period positive obligations · 5 awards
- Recorded activity
- Since Feb 3, 2022
- through Feb 2, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$1.5M
2.9%
Dollar movement
+$389K
vs. prior 12 months
Last 12mo awards
4 awards
16 actions
Historical and award details for BECKMAN COULTER GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG
- Obligations: prior → latest
- $1.2M → $1.5M
- +33.5%
- Share: prior → latest
- 2.5% → 2.9%
- +0.3 percentage points
- All-period obligations
- $2.7M
- 0.050% of all-period positive obligations · 5 awards
- Recorded activity
- Since Sep 26, 2024
- through Mar 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 4 3 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$1.3M
2.5%
Dollar movement
+$547K
vs. prior 12 months
Last 12mo awards
11 awards
12 actions
Historical and award details for SUMMIT SHOJI INC.
- Obligations: prior → latest
- $785K → $1.3M
- +69.6%
- Share: prior → latest
- 1.7% → 2.5%
- +0.8 percentage points
- All-period obligations
- $4.6M
- 0.080% of all-period positive obligations · 63 awards
- Recorded activity
- Since Jan 12, 2022
- through Apr 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 11 11 Reported small business 0 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$1.3M
2.5%
Dollar movement
+$744K
vs. prior 12 months
Last 12mo awards
24 awards
49 actions
Historical and award details for WERFEN USA LLC
- Obligations: prior → latest
- $574K → $1.3M
- +129.8%
- Share: prior → latest
- 1.3% → 2.5%
- +1.2 percentage points
- All-period obligations
- $2.5M
- 0.050% of all-period positive obligations · 44 awards
- Recorded activity
- Since Oct 13, 2021
- through Apr 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 15 15 Not reported 9 9 Reported small business 4 4 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$1.1M
2.1%
Dollar movement
+$570K
vs. prior 12 months
Last 12mo awards
3 awards
3 actions
Historical and award details for ONE LAMBDA, INC.
- Obligations: prior → latest
- $556K → $1.1M
- +102.5%
- Share: prior → latest
- 1.2% → 2.1%
- +0.9 percentage points
- All-period obligations
- $3.1M
- 0.060% of all-period positive obligations · 13 awards
- Recorded activity
- Since Feb 17, 2022
- through Mar 11, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 4 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
Award activity for In-Vitro Diagnostic Substance Manufacturing at the Department of Defense
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
Modification
This action
+$1.9M
ROCHE DIAGNOSTICS CORPORATION
AMC MADIGAN LEWIS - MM
REAGENTS, SUPPLIES, TRAINING AND MAINTENANCE FOR THE GOVERNMENT OWNED ROCHE DIAGNOSTIC TOTAL LABORATORY AUTOMATION SYSTEM.
Why it stands out
The award grew alongside stronger contractor activity.
The modification added $1.9M while contractor obligations rose $4.0M overall.
- Award net obligations
- $1.9M
- Share of 12-month positive obligations
- 3.6%
Supporting data
- Prime contractor
- #1 · 16.9% share
- +5.8 percentage points · $4.0M net increase; action accounted for 48.7%
- Funding office
- #2 · 9.4% attributed share
- up 7 ranks · +6.1 percentage points · $3.4M net increase; action accounted for 58.0%
Related:Largest share gain
Modification
This action
+$1.5M
BECKMAN COULTER, INC
ACH BENNING - MM
RELEASE OF FY26 FUNDS
Why it stands out
The contractor climbed 3 positions in this market.
It now ranks #4 by positive obligations over the latest 12 months.
- Award net obligations
- $1.5M
- Share of 12-month positive obligations
- 2.8%
Supporting data
- Prime contractor
- #4 · 4.7% share
- up 3 ranks · +1.2 percentage points · $925K net increase; action exceeded it by $568K
Modification
This action
+$1.5M
ABBOTT MOLECULAR INC.
AMC BAMC FSH - MM
FOR MOLECULAR TRANSPLANT, RESPIRATORY, AND SEXUAL HEALTH TESTING DEPARTMENT OF PATHOLOGY AND AREA LABORATORY SERVICES
Why it stands out
The award grew alongside stronger contractor activity.
The modification added $1.5M while contractor obligations rose $1.7M overall.
- Award net obligations
- $1.5M
- Share of 12-month positive obligations
- 2.8%
Supporting data
- Prime contractor
- #11 · 3.1% share
- +3.1 percentage points · $1.7M net increase; action accounted for 91.5%
Modification
This action
+$1.1M
BIOFIRE DEFENSE LLC
AMC BAMC FSH - MM
IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.218, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K00-25-P-A095 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026.
Why it stands out
The contractor climbed 10 positions in this market.
It now ranks #3 by positive obligations over the latest 12 months.
- Award net obligations
- $1.3M
- Share of 12-month positive obligations
- 2.0%
Supporting data
- Prime contractor
- #3 · 5.3% share
- up 10 ranks · +3.1 percentage points · $1.8M net increase; action accounted for 59.9%
Related:Largest rank gain
Modification
This action
+$923K
DIASORIN INC
AMC BAMC FSH - MM
IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K00-25-P-A125 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026.
Why it stands out
The contractor climbed 6 positions in this market.
It now ranks #6 by positive obligations over the latest 12 months.
- Award net obligations
- $923K
- Share of 12-month positive obligations
- 1.7%
Supporting data
- Prime contractor
- #6 · 4.3% share
- up 6 ranks · +2.1 percentage points · $1.3M net increase; action accounted for 71.2%
Modification
This action
+$679K
BIO RAD LABORATORIES INC
AHC MONCRIEF JACKSON - MM
PATHOLOGY TESTING REQUIREMENT
Why it stands out
The contractor climbed 21 positions in this market.
It now ranks #16 by positive obligations over the latest 12 months.
- Award net obligations
- $719K
- Share of 12-month positive obligations
- 1.3%
Supporting data
- Funding office
- #9 · 3.3% attributed share
- up 11 ranks · +1.7 percentage points · $952K net increase; action accounted for 71.3%
View recent award activity by date (10)
- Action+$655Award net obligations$655
- Action−$5KAward net obligations$517K
- Action+$5KAward net obligations$5K
- Action+$79Award net obligations$79
- Action+$23KAward net obligations$23K
- Action+$2KAward net obligations$2K
- Action−$247Award net obligations$134K
- Action+$183KAward net obligations$183K
- Action+$63KAward net obligations$63K
- Action+$61KAward net obligations$205K
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Reported obligations include contract actions from October 1, 2021 through July 27, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.
Review data methodology